StackLeaf
← Back to feed
VERIFIEDET Finance·positive

Zydus Lifesciences acquires US pharma firm Assertio for $166 million

AI Summary
  • ·Zydus Lifesciences has acquired US pharma firm Assertio Holdings for $166.40 million.
  • ·The acquisition includes Assertio's cancer treatment, Rolvedon.
  • ·This move aims to strengthen Zydus' position in the US specialty oncology market.
ZYDUSLIFE
Read original →